• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西诺沙星用于尿路感染:理论与实践考量

Cinoxacin in urinary tract infections. Theoretical and practical considerations.

作者信息

Madsen P O, Frimodt-Møller N, Maigaard S, Nielsen O S, Rodriguez N, Welling P G

出版信息

Urology. 1981 May;17(5):496-9. doi: 10.1016/0090-4295(81)90204-1.

DOI:10.1016/0090-4295(81)90204-1
PMID:7233671
Abstract

In dogs we found that cinoxacin concentrations in prostatic tissue, secretion, and interstitial fluid always were lower than the simultaneous serum concentrations, during constant infusion experiments. The cinoxacin concentrations in urethral and vaginal secretions were similar to those found in prostatic interstitial fluid, approximately one third to one fourth of the simultaneous serum concentrations. The concentrations of cinoxacin in human prostatic tissue after single or multiple doses of 500 mg. were found to be in the range of minimum inhibitory concentrations for most microorganisms found in urinary tract infections. Cinoxacin was found to have a half-life of 2.7 hours in patients with normal renal function, but increased to 8.5 hours in patients with impaired renal function. We found little or no drug accumulation during a seven-day treatment of patients with impaired renal function.

摘要

在犬类实验中,我们发现在持续输注实验期间,环丙沙星在前列腺组织、分泌物和间质液中的浓度始终低于同时期的血清浓度。环丙沙星在尿道和阴道分泌物中的浓度与在前列腺间质液中发现的浓度相似,约为同时期血清浓度的三分之一至四分之一。单次或多次服用500毫克后,人体前列腺组织中环丙沙星的浓度对于大多数尿路感染中发现的微生物而言处于最低抑菌浓度范围内。我们发现,肾功能正常的患者中环丙沙星的半衰期为2.7小时,但肾功能受损的患者中该半衰期延长至8.5小时。我们还发现,在对肾功能受损的患者进行为期七天的治疗期间,几乎没有药物蓄积现象。

相似文献

1
Cinoxacin in urinary tract infections. Theoretical and practical considerations.西诺沙星用于尿路感染:理论与实践考量
Urology. 1981 May;17(5):496-9. doi: 10.1016/0090-4295(81)90204-1.
2
Rosoxacin and cinoxacin distribution in prostate, vagina, and female urethra. An experimental study in dogs.罗索沙星和西诺沙星在前列腺、阴道及女性尿道中的分布:一项犬类实验研究
Invest Urol. 1979 Sep;17(2):149-52.
3
Cinoxacin: mechanism of action, spectrum of activity, pharmacokinetics, adverse reactions, and therapeutic indications.
Pharmacotherapy. 1982 Sep-Oct;2(5):266-72. doi: 10.1002/j.1875-9114.1982.tb03195.x.
4
Cinoxacin: pharmacokinetics and tolerance in patients with normal and impaired renal function.西诺沙星:肾功能正常和受损患者的药代动力学及耐受性
Antimicrob Agents Chemother. 1979 Sep;16(3):411-6. doi: 10.1128/AAC.16.3.411.
5
Cinoxacin. A review of its pharmacological properties and therapeutic efficacy in the treatment of urinary tract infections.西诺沙星。其药理学特性及治疗尿路感染疗效的综述。
Drugs. 1983 Jun;25(6):544-69. doi: 10.2165/00003495-198325060-00002.
6
Cinoxacin (Cinobac) for urinary tract infections.
Drug Ther Bull. 1980 Jun 6;18(12):47-8.
7
Cinoxacin and nalidixic acid in treatment of urinary tract infections.
Urology. 1981 May;17(5):500-1. doi: 10.1016/0090-4295(81)90205-3.
8
Cinoxacin (Cinobac)--a new drug for urinary tract infections.
Med Lett Drugs Ther. 1981 Jun 26;23(13):57-8.
9
Cinoxacin and trimethoprim with sulfamethoxazole in the treatment of infections of the urinary tract: a clinical comparison.
J Am Osteopath Assoc. 1982 Aug;81(12):843-5.
10
Cinoxacin for treatment and prevention of recurrent urinary tract infection.
Urology. 1981 May;17(5):505-10. doi: 10.1016/0090-4295(81)90207-7.

引用本文的文献

1
Cinoxacin. A review of its pharmacological properties and therapeutic efficacy in the treatment of urinary tract infections.西诺沙星。其药理学特性及治疗尿路感染疗效的综述。
Drugs. 1983 Jun;25(6):544-69. doi: 10.2165/00003495-198325060-00002.